Prevymis (letermovir) - Merck (MSD)
Letermovir use for CMV prophylaxis in lung transplant recipients : A single center experience (IDWeek 2025) - Sep 3, 2025 - Abstract #P-2190; Pres time: Oct 22, 2025; 12:15 PM - 01:30 PM; Location: Poster Hall B4-B5; No abstract available 
Clinical • Infectious Disease
https://idweek2025.eventscribe.net/fsPopup.asp?PosterID=760011&mode=posterInfo
 
Mario A. Torres, MD; Joanna K. Nelson, MD (she/her/hers); Koray Demir, MD; Alex Zimmet, MD; Aruna Subramanian, MD (she/her/hers); Thomas Dieringer, MD
 
Sep 3, 2025
 
Prev Next